According to previous publications, it is well-known that PMN-MDSCs rely to a large degree on the expression of Arg-1 to exert an immunosuppressive capacity [42,43] and that angiogenic factors in the tumor microenvironment can induce the differentiation of myeloid immune suppressor cells toward endothelial cells [24]. The gene discussed is ARG1; the disease is neoplasm.